224 related articles for article (PubMed ID: 28739745)
21. Expression and Significances of MTSS1 in Pancreatic Cancer.
Zhou L; Li J; Shao QQ; Guo JC; Liang ZY; Zhou WX; Zhang TP; You L; Zhao YP
Pathol Oncol Res; 2016 Jan; 22(1):7-14. PubMed ID: 26198729
[TBL] [Abstract][Full Text] [Related]
22. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.
Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY
Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744
[TBL] [Abstract][Full Text] [Related]
23. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer.
Hu Y; Wang F; Xu F; Fang K; Fang Z; Shuai X; Cai K; Chen J; Hu P; Chen D; Xu P; Hu C; Zeng Z; Zhong J; Li W; Tang J; Huang M; Zhao Y; Wang C; Zhao G
Theranostics; 2020; 10(22):10120-10140. PubMed ID: 32929338
[No Abstract] [Full Text] [Related]
24. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
25. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
26. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
27. AID modulates carcinogenesis network via DNA demethylation in bladder urothelial cell carcinoma.
Li H; Li Q; Ma Z; Zhou Z; Fan J; Jin Y; Wu Y; Cheng F; Liang P
Cell Death Dis; 2019 Mar; 10(4):251. PubMed ID: 30874539
[TBL] [Abstract][Full Text] [Related]
28. Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.
Naito S; Bilim V; Yuuki K; Ugolkov A; Motoyama T; Nagaoka A; Kato T; Tomita Y
Clin Cancer Res; 2010 Nov; 16(21):5124-32. PubMed ID: 20889919
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
30. Aberrant FHIT expression is linked to bladder carcinogenesis and apoptosis.
Han Y; Zhang Z; Zhang GJ; Guo KF; Shan GY; Kong CZ
Asian Pac J Cancer Prev; 2011; 12(11):2915-20. PubMed ID: 22393963
[TBL] [Abstract][Full Text] [Related]
31. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
[TBL] [Abstract][Full Text] [Related]
32. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
Immunobiology; 2015 Jan; 220(1):68-73. PubMed ID: 25214475
[TBL] [Abstract][Full Text] [Related]
33. Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia.
Schemionek M; Kharabi Masouleh B; Klaile Y; Krug U; Hebestreit K; Schubert C; Dugas M; Büchner T; Wörmann B; Hiddemann W; Berdel WE; Brümmendorf TH; Müller-Tidow C; Koschmieder S
PLoS One; 2015; 10(5):e0125783. PubMed ID: 25996952
[TBL] [Abstract][Full Text] [Related]
34. EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer.
Kedmi M; Ben-Chetrit N; Körner C; Mancini M; Ben-Moshe NB; Lauriola M; Lavi S; Biagioni F; Carvalho S; Cohen-Dvashi H; Schmitt F; Wiemann S; Blandino G; Yarden Y
Sci Signal; 2015 Mar; 8(368):ra29. PubMed ID: 25783158
[TBL] [Abstract][Full Text] [Related]
35. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.
Zeleniak AE; Huang W; Brinkman MK; Fishel ML; Hill R
Oncotarget; 2017 Mar; 8(10):16473-16487. PubMed ID: 28146435
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q
Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of MTSS1 expression is an independent prognosticator in squamous cell carcinoma of the lung.
Kayser G; Csanadi A; Kakanou S; Prasse A; Kassem A; Stickeler E; Passlick B; Zur Hausen A
Br J Cancer; 2015 Mar; 112(5):866-73. PubMed ID: 25625275
[TBL] [Abstract][Full Text] [Related]
38. Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Rath SK; Dalela D; Goel MM; Bhatt ML
Immunobiology; 2015 Jan; 220(1):103-8. PubMed ID: 25178936
[TBL] [Abstract][Full Text] [Related]
39. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
[TBL] [Abstract][Full Text] [Related]
40. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
Xu ST; Ding X; Ni QF; Jin SJ
Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]